Highlights Laurus Labs Limited

Equities

LAURUSLABS

INE947Q01028

Delayed NSE India S.E. Other stock markets 05:00:37 2024-05-09 am EDT			5-day change	1st Jan Change
430.7 ^INR	-0.78%		-4.30%	+0.15%

Apr. 25	Transcript : Laurus Labs Limited, Q4 2024 Earnings Call, Apr 25, 2024
Apr. 25	Laurus Labs' Consolidated Profit Falls in Fiscal Q4	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Laurus Labs' Consolidated Profit Falls in Fiscal Q4	Apr. 25	MT
Laurus Labs Limited Approves Second Interim Dividend for the Financial Year 2023-2024, Payable on or After May 17, 2024	Apr. 25	CI
Laurus Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2024	Apr. 25	CI
Laurus Labs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	Apr. 25	CI
Laurus Labs Board to Consider Second Interim Dividend for Fiscal Year 2024	Apr. 18	MT
Laurus Labs Incorporates New JV Company with Slovenia-Based Pharmaceutical Company	Apr. 15	MT
Laurus Labs, Slovenia's Krka to Form JV; Laurus Shares Fall 6%	Jan. 26	MT
Laurus Labs Limited Reaches to Agreement with Krka to Establish Joint Venture Company in Hyderabad, India Namely Krka Pharma Pvt. Ltd	Jan. 25	CI
Laurus Labs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Jan. 24	CI
Laurus Labs Completes Acquisition of Additional Stake in Laurus Bio	Nov. 21	MT
Laurus Labs Limited completed the acquisition of additional 14.54% stake in Laurus Bio Private Limited from one of the Promoters, non-executive director, his family members and few Employee/ex-Employee shareholders.	Nov. 19	CI
Laurus Labs Limited Approves Interim Dividend, Payable on or After November 09, 2023	23-10-20	CI
Laurus Labs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	23-10-20	CI
Laurus Labs Limited agreed to acquire an additional 14.54% stake in Laurus Bio Private Limited from one of the Promoters, non-executive director, his family members and few Employee/ex-Employee shareholders for approximately INR 720 million.	23-09-10	CI
India's Divi's Labs Q1 profit slumps on drug pricing pressures	23-08-14	RE
Laurus Labs' Consolidated Profit Tanks in Fiscal Q1; Shares Climb 4%	23-07-31	MT
Laurus Labs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-07-27	CI
Laurus Labs Pays First Tranche to Acquire Additional Stake in Cell and Gene Therapy Company	23-07-12	MT
Laurus Labs Ties Up with Indian Institute for Novel Gene Therapy Advancement in India	23-06-19	MT
Laurus Labs Signs Memorandum of Agreement with IIT Kanpur for Novel Gene Therapy Assets	23-06-19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Laurus Labs Limited

Equities

LAURUSLABS

INE947Q01028

Highlights

Filters